We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.31B
AUM Growth
-$51.4M
Cap. Flow
-$54.7M
Cap. Flow %
-4.18%
Top 10 Hldgs %
12.11%
Holding
1,682
New
422
Increased
338
Reduced
347
Closed
506

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$18.2M
2
TER icon
Teradyne
TER
+$15.9M
3
BE icon
Bloom Energy
BE
+$15.3M
4
CYBR
CyberArk
CYBR
+$15.2M
5
EXAS
Exact Sciences
EXAS
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Healthcare 14.62%
3 Consumer Discretionary 10.89%
4 Industrials 8.81%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FF icon
1101
Future Fuel
FF
$217M
$66.3K 0.01%
+17,214
New +$64.6K
FRMI
1102
Fermi Inc
FRMI
$3.63B
$65.7K 0.01%
+11,251
New +$98.5K
AIOT
1103
PowerFleet Inc
AIOT
$526M
$65K 0.01%
21,101
-8,007
-28% -$33.5K
IMA
1104
ImageneBio Inc
IMA
$63M
$65K 0.01%
12,990
-505
-4% -$3.28K
NL icon
1105
NLI Holdings
NL
$281M
$63.1K ﹤0.01%
+10,829
New +$65.3K
GPRO icon
1106
GoPro
GPRO
$130M
$62.2K ﹤0.01%
80,775
+10,815
+15% +$10.9K
CVGI icon
1107
Commercial Vehicle Group
CVGI
$154M
$61.8K ﹤0.01%
+18,125
New +$37.3K
RXST icon
1108
RxSight
RXST
$249M
$61.6K ﹤0.01%
+10,000
New +$83K
VYGR icon
1109
Voyager Therapeutics
VYGR
$183M
$60.6K ﹤0.01%
+15,712
New +$61.9K
LNSR icon
1110
LENSAR
LNSR
$61.5M
$59.7K ﹤0.01%
+10,017
New +$109K
WEAV icon
1111
Weave Communications
WEAV
$520M
$59.6K ﹤0.01%
+12,890
New +$75.1K
LFCR icon
1112
Lifecore Biomedical
LFCR
$166M
$59.5K ﹤0.01%
16,004
-2,823
-15% -$19.5K
URG
1113
Ur-Energy
URG
$485M
$59.4K ﹤0.01%
+39,896
New +$65.1K
NUVB icon
1114
Nuvation Bio
NUVB
$2.2B
$58.3K ﹤0.01%
+13,583
New +$75.7K
FGNX
1115
FG Nexus Inc
FGNX
$41.6M
$58K ﹤0.01%
11,619
-31,100
-73% -$317K
BIVIW
1116
BioVie Inc Warrant
BIVIW
$156K
$57.9K ﹤0.01%
186,621
SWIM icon
1117
Latham Group
SWIM
$629M
$57.7K ﹤0.01%
10,746
-11,114
-51% -$70.8K
CTKB icon
1118
Cytek Biosciences
CTKB
$545M
$57.7K ﹤0.01%
13,200
-200
-1% -$944
DNN icon
1119
Denison Mines
DNN
$2.54B
$57.5K ﹤0.01%
16,286
+5,421
+50% +$20.4K
API
1120
Agora
API
$338M
$56.6K ﹤0.01%
+16,000
New +$67.8K
BULL
1121
Webull Corp
BULL
$3.75B
$55.9K ﹤0.01%
+11,645
New +$75.4K
OMSE
1122
OMS Energy Technologies
OMSE
$179M
$55.2K ﹤0.01%
12,956
-672
-5% -$3.08K
OCGN icon
1123
Ocugen
OCGN
$416M
$52.8K ﹤0.01%
+29,149
New +$50.4K
OBIO icon
1124
Orchestra BioMed
OBIO
$238M
$52.7K ﹤0.01%
+12,389
New +$52.7K
AGEN
1125
Agenus
AGEN
$312M
$49.8K ﹤0.01%
14,900
+400
+3% +$1.33K

Similar funds

Prelude Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Prelude Capital Management held 1,682 positions worth $1.31B, down 3.8% from $1.36B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $54.7M in Q1 2026, closing 506 positions and reducing 347 holdings. Its most notable exit was CyberArk, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Appian worth $9.41M.

  • Prelude Capital Management's largest Q1 2026 buy was Appian: 390,321 shares worth $9.41M.
  • Prelude Capital Management added most to Penumbra in Q1 2026, an estimated $15.3M increase.
  • Prelude Capital Management's biggest Q1 2026 reduction was SPDR Gold Trust, cutting an estimated $18.2M.
  • Prelude Capital Management fully exited CyberArk in Q1 2026, selling an estimated $15.2M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.31B portfolio in Q1 2026.
  • Prelude Capital Management opened 422 new positions and closed 506 in Q1 2026.
  • Prelude Capital Management's portfolio value fell 3.8% quarter-over-quarter to $1.31B.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.